Q9-19: Current Hematologic Findings

!Current Hematologic Findings
Current hematologic findings questions can only be completed on the 100-day, 6-month, 1 year, and 2 year follow-up forms. These questions will be disabled for all subsequent reporting periods.

!Lymphodepleting Therapy and Current Hematologic Findings
The following questions are enabled only if the recipient received lymphodepleting therapy as reported on the Pre-CTED (4000) form.

*Combined Follow-Up
In scenarios where an HCT was given after a cellular therapy and this form is now being completed based on the subsequent HCT date, these questions do not apply and are disabled if there is an associated Post-HCT Data (2100) form.

Questions 9-18: Complete blood count results available (check all that apply)

These questions are intended to determine the hematological status of the recipient after the infusion. Testing may be performed multiple times within the reporting period; however, report the most recent (closest to the contact date) laboratory values.

Report the date of the most recent complete blood count in the reporting period and select all hematologic results available. Report the associated laboratory value and unit of measurement (if applicable).

For hematocrit, check the box if red blood cells were transfused within 30 days prior to the testing.

For platelets, check the box if platelets were transfused within seven days prior to the testing.

Questions 19: Did the recipient receive any growth factors +<+7 days before the date the sample was drawn?

Indicate if the recipient received any growth factor (e.g., GCS-F) within seven days prior to the date the CBC sample was drawn (reported above). In the event of a long-acting growth factor (e.g., pegfilgrastim (Neulasta®)), report Yes if the recipient received it within 14 days prior to the date the CBC sample was drawn, as reported above.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2026 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.